Real-time funding, M&A, exec moves & hiring — the signals that move deals
More real-time opportunities that match your ICP — every funding, M&A, and exec move the moment it breaks, with the verified contacts to reach out first.
Jubilant Ingrevia Limited has completed its acquisition of 100% equity in Remidex Pharma Private Limited on March 30, 2026. This strategic move enhances Jubilant Ingrevia's presence in the pharmaceutical sector by gaining operational control over Remidex Pharma. The acquisition follows an initial agreement announced on March 13, 2026, showcasing the company's dedication to growth through strategic acquisitions.
Company Information
Company
Jubilant Ingrevia Limited
Location
Noida, Uttar Pradesh, India
About
Jubilant Ingrevia Limited is a global leader in the pharmaceutical and specialty chemicals sector. The company specializes in custom synthesis and manufacturing of active pharmaceutical ingredients (APIs). It is committed to delivering high-quality products to enhance health and wellbeing.
Noida